Through our continued Strategic Investments, we are building a portfolio of promising clinical and pre-clinical stage drug candidates. We believe they will improve people’s lives by creating access to innovative medicine across some of our key therapeutic areas including oncology and respiratory.
invoX is the investor and key shareholder of Karolinska Development, which invests in Nordic companies, developing potentially ground-breaking treatments to relieve or cure serious diseases.More info
Treadwell Therapeutics Inc.
Treadwell is a science-first organisation leveraging deep mechanistic insights and cutting-edge tools to uncover novel targets and to translate those insights into clinical candidates. With a robust set of internal discovery tools and capabilities at the Toronto-based R&D hub, Treadwell is intently focused on translating innovative scientific ideas and therapeutic targets into practice-changing medicines.More info